申请人:OSI Pharmaceuticals Inc.
公开号:US20030139427A1
公开(公告)日:2003-07-24
This invention pertains to compounds which specifically bind to the adenosine A1, A2a, and A3 receptors and the use of these compounds to treat a disease associated with the A1, A2a, and A3 adenosine receptors in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.
本发明涉及与腺苷 A1、A2a 和 A3 受体特异性结合的化合物,以及使用这些化合物治疗受试者体内与腺苷 A1、A2a 和 A3 受体相关的疾病,包括向受试者施用治疗有效量的化合物。